| Literature DB >> 24531453 |
Beth A Taylor1, Amanda L Zaleski, Jeffrey A Capizzi, Kevin D Ballard, Christopher Troyanos, Aaron L Baggish, Pierre A D'Hemecourt, Marcin R Dada, Paul D Thompson.
Abstract
OBJECTIVES: The effect of habitual, high-intensity exercise training on the progression of atherosclerosis is unclear. We assessed indices of vascular health (central systolic blood pressure (SBP) and arterial stiffness as well as carotid intima-medial thickness (cIMT)) in addition to cardiovascular risk factors of trained runners versus their untrained spouses or partners to evaluate the impact of exercise on the development of carotid atherosclerosis.Entities:
Keywords: Sports Medicine
Mesh:
Substances:
Year: 2014 PMID: 24531453 PMCID: PMC3927935 DOI: 10.1136/bmjopen-2013-004498
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Participant characteristics
| Runners | Controls | |
|---|---|---|
| Sample size (n) | 42 | 42 |
| Women (n) | 21 | 21 |
| Age (years) | 46±13 | 46±12 |
| Height (inches) | 67±5 | 67±5 |
| Weight (lbs) | 149±24* | 170±42 |
| Meds (n) | ||
| BP lowering | 1 | 5 |
| NSAIDs | 3 | 2 |
| Aspirin | 1 | 1 |
| Cholesterol lowering | 2 | 4 |
| Oral contraceptives | 5 | 2 |
| Family history of CVD (n) | 15 | 10 |
| Race time (h:min) | 4:20±0:47 | – |
| Running mileage | 40±16 | – |
| Years run | 12±10 | – |
| Marathons completed (n) | 16±30 | – |
| Average vigorous exercise/day (h) | 2.0±1.1* | 0.6±0.6 |
| Average moderate exercise/day (h) | 3.9±2.2 | 3.2±2.7 |
| Block fruit (pts) | 18.7±4.2 | 16.8±4.5 |
| Block meat (pts) | 11.5±5.4 | 13.1±5.8 |
*Significant difference between runners and controls (p<0.05).
BP, blood pressure; CVD, cardiovascular disease; NSAIDs, non-steroidal anti-inflammatory drugs.
Cardiovascular risk factors
| Runners | Controls | |
|---|---|---|
| Left cIMT (mm) | 0.60±0.09 | 0.62±0.11 |
| Right cIMT (mm) | 0.60±0.11 | 0.59±0.10 |
| SBP (mm Hg) | 130±18 | 127±17 |
| DBP (mm Hg) | 76±9 | 75±10 |
| HR (bpm) | 57±11* | 69±12 |
| BMI (kg/m2) | 24±4* | 27±5 |
| Framingham Risk (pts) | 3±4 | 3±3 |
| hsCRP | 0.6±0.5* | 1.6±1.9 |
| Total-C (mg/dL) | 181±29 | 188±32 |
| Non-HDL-C (mg/dL) | 114±31* | 131±32 |
| HDL-C (mg/dL) | 68±18* | 58±16 |
| LDL-C (mg/dL) | 99±27 | 110±28 |
| Triglycerides (mg/dL) | 76±29* | 103±58 |
| Central SBP (mm Hg) | 130±18 | 127±17 |
| Carotid AP (mm Hg) | 11±8 | 10±6 |
| AI@HR75 (%) | 14±11 | 20±11 |
*Significant difference between runners and controls (p<0.05).
AP, augmentation pressure; AI@HR75, augmentation index at heart rate 75 bpm; BMI, body mass index; C, cholesterol; cIMT, carotid intima-medial thickness; DBP, diastolic blood pressure; HDL, high density lipoprotein; HR, heart rate; hsCRP, high sensitivity C reactive protein; LDL, low density lipoprotein; SBP, systolic blood pressure.
Figure 1Relationships between age and left carotid intima-medial thickness (cIMT, A) and right cIMT (B) with data points represented for each individual participant and r2 value shown for the entire sample. Solid line indicates regression line for runners; dashed line indicates regression line for controls.
Figure 2Relationships between calculated Framingham Risk Score and left carotid intima-medial thickness (cIMT, A) and right cIMT (B) with data points represented for each individual participant and r2 value shown for the entire sample. Solid line indicates regression line for runners; dashed line indicates regression line for controls.
Figure 3Relationships between age and carotid augmentation pressure (A) and calculated Framingham Risk score and carotid augmentation pressure (B) with data points represented for each individual participant and r2 value shown for the entire sample. Solid line indicates regression line for runners; dashed line indicates regression line for controls.
Figure 4Relationship between age and carotid augmentation index with data points represented for each individual participant and r2 value shown for the entire sample. Solid line indicates regression line for runners; dashed line indicates regression line for controls.